Acute myeloid leukaemia trials in China

In China 226 Also abroad 763

226 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Early phase 1Taking people
XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia
Where
Shanghai
Age
18 years and over
People
60
Run by
Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06980155
Phase 2Taking people
Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia
Where
Beijing
Age
55 years to 70 years
People
56
Run by
Peking University People's Hospital
See details and how to joinNCT06869265
Phase 2/3Taking people
Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation
Where
Shanghai
Age
14 years to 75 years
People
126
Run by
Ruijin Hospital
See details and how to joinNCT06972641
No phaseEnrolling by invitation
Daunorubicin + Cytarabine + Venetoclax in de Novo AML
Where
Hefei
Age
18 years to 59 years
People
94
Run by
Anhui Medical University
See details and how to joinNCT06697327
Phase 1/2Taking people
Phase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Where
Guangzhou, Hangzhou
Age
18 years to 70 years
People
24
Run by
Guangzhou Bio-gene Technology Co., Ltd
See details and how to joinNCT06118788
Phase 1/2Taking people
The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors
Where
Tianjin
Age
18 years and over
People
90
Run by
Tianjin Medical University General Hospital
See details and how to joinNCT06911710
Phase 2Not yet taking people in China
Selinexor Combined With Azacitidine Therapy in High-Risk Myeloid Neoplasms Patients
Where
Tianjin
Age
16 years to 75 years
People
20
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06900088
Phase 1Taking people
UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
Where
Wuhan
Age
18 years to 60 years
People
9
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06245746
Phase 1Taking people
A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML)
Where
Hangzhou
Age
18 years and over
People
84
Run by
Zhejiang ACEA Pharmaceutical Co. Ltd.
See details and how to joinNCT05947344
No phaseTaking people
A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML
Where
Suzhou
Age
14 years to 70 years
People
40
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT06879847
Early phase 1Taking people
Off-the-shelf CD123 CAR-NK for R/R AML
Where
Beijing
Age
18 years and over
People
12
Run by
Peking University People's Hospital
See details and how to joinNCT06201247
Phase 1Taking people
CD123-CD16-NK Cells Immunotherapy for AML
Where
Beijing
Age
18 years to 70 years
People
9
Run by
Chunji Gao
See details and how to joinNCT06835140
Phase 1Taking people
Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML Patients
Where
Xiamen
Age
60 years to 75 years
People
18
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT06651866
Phase 1Taking people
Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML
Where
Xiamen
Age
18 years and over
People
30
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT06737523
No phaseNot yet taking people in China
Study of Tretinoin Capsules in Combination With Azacitidine and Venetoclax in Treatment Naïve Participants With Acute Myeloid Leukemia
Where
Suzhou
Age
18 years to 60 years
People
158
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT06841952
Phase 2Taking people
Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML
Where
Xiamen
Age
60 years and over
People
66
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT06827899
Phase 2Taking people
VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Where
Xiamen
Age
60 years and over
People
66
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT05603884
Phase 2Taking people
Chemotherapy CLAGE-Ven Sequential With Reduced Intensity Conditioning for Refractory Acute Myelodi Leukemia
Where
Shanghai
Age
16 years to 65 years
People
100
Run by
Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT05870995
Phase 3Taking people
Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies
Where
Fuzhou, Kunming, Nanjin, Nanning, Shanghai, Suzhou, Xiamen
Age
16 years to 55 years
People
222
Run by
Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT05991908
Phase 3Taking people
Conditioning Regimen of Melphalan-busulfan and Fludarabine: a Randomized Study of Different Dose of Melphalan
Where
Shanghai
Age
18 years to 55 years
People
120
Run by
Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06829472
Phase 3Taking people
HVA vs IA/DA or VA in the Treatment of ND HR-AML
Where
Guangzhou
Age
18 years and over
People
876
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT06810791
Phase 3Taking people
Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid Leukemia
Where
Beijing
Age
18 years to 70 years
People
96
Run by
Peking University People's Hospital
See details and how to joinNCT06802718
Early phase 1Not yet taking people in China
Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.
Where
Hangzhou
Age
18 years to 70 years
People
18
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06786299
Phase 2Taking people
Avapritinib Combined With Azacitidine and Venetoclax in the Treatment of Relapsed AML After Allo-HSCT
Where
Tianjin
Age
18 years and over
People
20
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06783790
Phase 2Not yet taking people in China
Avapritinib Maintenance for AML With KIT Mutations
Where
Shanghai
Age
14 years to 70 years
People
47
Run by
Ruijin Hospital
See details and how to joinNCT06765915